We are live on
!
Find out more
BIA
Biondo Investment Advisors Portfolio holdings
AUM
$780M
1-Year Est. Return
21.03%
This Fund
S&P 500
This Quarter
Est. Return
+7.07%
1 Year Est. Return
+21.03%
3 Year Est. Return
+89.14%
5 Year Est. Return
+116.93%
10 Year Est. Return
+716.37%
AUM
$280M
AUM Growth
-$22.4M
(-7.4%)
Cap. Flow
+$12.3M
Cap. Flow
% of AUM
4.39%
Top 10 Holdings %
Top 10 Hldgs %
45.13%
Holding
86
New
11
Increased
25
Reduced
35
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPM.WS
JPMorgan Chase
JPM.WS
|
+$16.1M |
| 2 |
Gilead Sciences
GILD
|
+$7.44M |
| 3 |
Ford
F
|
+$4.89M |
| 4 |
iShares MSCI Belgium ETF
EWK
|
+$2.36M |
| 5 |
Intuitive Surgical
ISRG
|
+$2.08M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
|
+$5.04M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
+$3.58M |
| 3 |
ABMD
Abiomed Inc
ABMD
|
+$3.46M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$3.44M |
| 5 |
Lowe's Companies
LOW
|
+$3.02M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 27.66% |
| 2 | Financials | 12.12% |
| 3 | Energy | 11.81% |
| 4 | Communication Services | 9.71% |
| 5 | Consumer Discretionary | 6.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GCVRZ
76
DELISTED
Sanofi Contingent Value Rights
GCVRZ
| $4K | ﹤0.01% |
15,650
+725
| +5% | +$318 |
|
77
Align Technology
ALGN
$12.1B
| – | – |
-3,400
| Closed | -$327K |
|
78
iShares MSCI New Zealand ETF
ENZL
$77.3M
| – | – |
-53,220
| Closed | -$2.11M |
|
79
iShares MSCI Brazil ETF
EWZ
$9.28B
| – | – |
-52,045
| Closed | -$1.74M |
|
|
80
Lowe's Companies
LOW
$117B
| – | – |
-42,505
| Closed | -$3.02M |
|
81
NBT Bancorp
NBTB
$2.74B
| – | – |
-5,555
| Closed | -$233K |
|
82
PNC Financial Services
PNC
$99.7B
| – | – |
-2,266
| Closed | -$265K |
|
83
Ulta Beauty
ULTA
$22B
| – | – |
-3,195
| Closed | -$815K |
|
|
EGRX
84
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| – | – |
-63,575
| Closed | -$5.04M |
|
|
ABMD
85
DELISTED
Abiomed Inc
ABMD
| – | – |
-30,724
| Closed | -$3.46M |
|
|
WES
86
DELISTED
Western Gas Partners Lp
WES
| – | – |
-3,700
| Closed | -$217K |
|
Similar funds
LA
SG
RTM
TCMX
QCMNJ
TIS
MO
NCM
Biondo Investment Advisors's Q1 2017 Portfolio in Review
As of Q1 2017, Biondo Investment Advisors held 86 positions worth $280M, down 7.4% from $302M the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Biondo Investment Advisors deployed $12.3M of net new capital in Q1 2017, opening 11 new positions and adding to 25 existing holdings. Its largest new stake was Gilead Sciences: 105,815 shares worth $8.83M.
By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 26% a quarter earlier, followed by Financials and Energy.
On the sell side, the largest reduction was Regeneron Pharmaceuticals, an estimated $3.58M trimmed.
- Biondo Investment Advisors's largest Q1 2017 buy was Gilead Sciences: 105,815 shares worth $8.83M.
- Biondo Investment Advisors added most to JPMorgan Chase in Q1 2017, an estimated $16.1M increase.
- Biondo Investment Advisors's biggest Q1 2017 reduction was Regeneron Pharmaceuticals, cutting an estimated $3.58M.
- Biondo Investment Advisors fully exited Eagle Pharmaceuticals, Inc. in Q1 2017, selling an estimated $5.04M.
- Biondo Investment Advisors's ten largest holdings make up 45% of its $280M portfolio in Q1 2017.
- Biondo Investment Advisors opened 11 new positions and closed 10 in Q1 2017.
- Biondo Investment Advisors's portfolio value fell 7.4% quarter-over-quarter to $280M.
Based on Biondo Investment Advisors's 13F filing for Q1 2017, filed 1 May 2017.